Status:
COMPLETED
The NOR-COR Study for Coronary Prevention
Lead Sponsor:
Vestre Viken Hospital Trust
Collaborating Sponsors:
The Hospital of Vestfold
Oslo University Hospital
Conditions:
Secondary Coronary Prevention
Eligibility:
All Genders
18-80 years
Brief Summary
The NOR-COR study is a cross-sectional, observational study designed to explore a large number of cardiovascular, inflammatory, genetic, behavioral, and psychosocial factors (including anxiety, depres...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- All patients aged 18-80 years with first or recurrent diagnosis or treatments for CHD: a) acute myocardial infarction \[ICD-10; I21\], b) coronary artery by-pass graft operation (CABG), or c) elective or emergency PCI \[ICD-10; I25\]) have been identified from hospital patient discharge lists (diagnostic lists) by searching chronologically after last admission the past three years. In patients with recurrent diagnosis the last event will define the event.
- Exclusion Criteria:
- Cognitive impairment that would invalidate assessment including all patients living at nursing home and psychosis.
- Short life expectancy (i.e. \<1 year) due to terminal heart (NYHA class 4), lung (chronic obstructive pulmonary disease GOLD 4)-, liver- or kidney disease (chronic kidney disease stage 5), malignant disease, or other reason.
- Not able to understand and write the Norwegian language or refuse to give written informed consent to study participation.
Exclusion
Key Trial Info
Start Date :
February 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
975 Patients enrolled
Trial Details
Trial ID
NCT02309255
Start Date
February 1 2014
End Date
April 1 2015
Last Update
June 15 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vestre Viken HF, Drammen Hospital and The Hospital of Vestfold
Drammen and Tønsberg, Buskerud and Vestfold, Norway, N-3004